This website is for US healthcare professionals

close-icon

Log In to Bolder Science

or

Don't have an account? Sign Up

close-icon

Please enter your email address.

You will receive a link to create a new password via email.

Log In

close-icon

Create an Account

or
  • 8 characters minimum
  • First character may not be a number
  • Last character may not be a number
close-icon

Welcome and thank you for creating an account!

At Bolder Science, we want your clinical trial search experience to be the best it can be. Complete the following prompts to easily find the trials you are interested in and see trials recruiting near you. You can adjust these selections in your dashboard after creating your account.

Condition Categories

Condition categories are pulled directly from ClinicalTrials.gov. Choose 1 or more condition categories that you are interested in:

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

Set a default location

Intra-uterine Fetal Brain Activity Monitoring.

  • Clinicaltrials.gov identifier

    NCT03930277

  • Recruitment Status

    Not yet recruiting

  • First Posted

    April 29, 2019

  • Last update posted

    May 4, 2021

Study Description

Brief summary:

Fetal cardiac monitoring is used during labor. Fetal decelerations may imply fetal hypoxia and distress. Brain activity monitoring is not used to evaluate fetal distress during labor. In this study the investigators intend to use an EEG based algorithm to evaluate and monitor fetal brain activity during the 2nd stage of labor.

  • Condition or Disease:Fetal Hypoxia
  • Intervention/Treatment: Diagnostic Test: Electroencephalogram
  • Phase: N/A

Detailed Description

Fetal heart rate (FHR) monitoring is commonly used in order to reduce fetal intrapartum asphyxia or any associated long-term disabilities. The electronic fetal monitoring (EFM) was first described by Hon and others during the 1960s (1) (2) and introduced into clinical practice before any clear evidence of benefits had been demonstrated. The EFM records the fetal heart rate, and characteristics such as baseline, accelerations, decelerations and variability are constantly evaluated in order to assess the hypoxic condition of the fetus and to identify fetal distress. Nevertheless, most of the studies (3-5) demonstrated that abnormal patterns of the fetal heart rate are of low predictive value for intrapartum fetal hypoxia or metabolic acidosis. Among high-risk pregnant woman, the probability of fetal metabolic acidosis in the presence of repeated, variable decelerations is 25%, and 48% in the presence of late decelerations (6). According to the Cochrane review (7) EFM didn't decrease the rates of cerebral palsy (CP), asphyxias complications or perinatal morbidity. The positive predictive value of non-reassuring FHR patterns for the prediction of CP among singleton newborns with birth weight of 2500 grams or more is only 0.14% (8). Hypoperfusion to a certain brain areas involves the rapid loss of brain function due to disturbances in brain blood supply. EEG shows typical changes in brain ischemia. These changes include: attenuation of faster waves, particularly in the beta and alpha frequency bands; enhancement of slower waves, mainly in the delta frequency band; regional attenuation without delta enhancement (RAWOD) and reduction of variability in the EEG signal (9). However, reaching effective sensitivity and specificity in immediate brain ischemia detection on the basis of EEG changes is still considered a challenge, as it depends on the presence of a skilled expert in neurophysiology to analyses raw EEG data in real-time. The investigators developed a unique platform algorithm, which analyses EEG data, and recognizes patients suffering from brain ischemia (stroke), based on the phenomena of interhemispheric decreased synchronization. Interhemispheric synchronization is the measure of correlation in EEG activity between ipsilateral and contralateral hemispheres, where values range between 1 (complete synchronization) and 0 (no synchronization). Increased synchronization means greater correlation between related ipsilateral and contralateral activities and vice versa for decreased synchronization. Normal brains should have a high correlation/ synchronization. Once brain ischemia occurs and the hemisphere is damaged, the interhemispheric synchronization decreases. In a recent study, we have shown the decrease in synchronization when a certain part of the brain is anaesthetized, causing a lesion similar to brain ischemia, and the recovery of synchronization, when the anesthesia recovered2. In another study, the investigators have tested the reliability of the algorithm in patients undergoing mechanical thrombectomy for acute stroke. In the study patients with acute stroke admitted to neuro angio intervention undergone short EEG test for 5 minutes. At the end of the procedure patients underwent a second short EEG test. In the test the interhemispheric synchronization were analyzed. It was shown that patients admitted to the neuro-angio intervention, who had brain tissue that might be salvable, had an average synchronization of 0.8. If the procedure succeeded and there was a clinical improvement - the synchronization remained high. If the procedure did not succeed, or succeed without clinical improvement, the synchronization decreased to an average of 0.65. Importantly, patients who were not candidates for neuro intervention, because they didn't have salvable brain, their index of synchronization was low to begin with (figure 1a and 1b). This preliminary assay proves the ability of the synchronization index to detect brain hypoperfusion that occurs, for example, in stroke. The objective of this proof of concept study is to test whether there is a correlation between the EEG index of interhemispheric synchronization, to the umbilical PH of the newborn and to the gold standard fetal heart rate monitor.

Study Design

  • Study Type: Observational
  • Estimated Enrollment: 20 participants
  • Observational Model: Cohort
  • Time Perspective: Prospective
  • Official Title: Using a New EEG Based Algorithm for Intra-uterine Fetal Brain Monitoring.
  • Estimated Study Start Date: July 2021
  • Estimated Primary Completion Date: December 2021
  • Estimated Study Completion Date: March 2022

Groups and Cohorts

Groups/Cohorts Intervention/treatment
: Pregnant women in labor.
Pregnant women in labor during the 2nd stage of labor.
Diagnostic Test: Electroencephalogram
Electroencephalogram for fetal brain activity monitoring.

Outcome Measures

  • Primary Outcome Measures: 1. Newborn blood gases [ Time Frame: From the beginning of the 2nd stage of labor up to 5 minutes postpartum. ]
    Correlation between the EEG index of interhemispheric synchronization, to the umbilical PH of the newborn and to the gold standard fetal heart rate monitor.

Eligibility Criteria

  • Ages Eligible for Study: 18 to 45 Years (Adult)
  • Sexes Eligible for Study: Female
  • Accepts Healthy Volunteers:
  • Sampling Method: Non-Probability Sample
  • Study Population: Pregannt women during the 2nd stage of labor at full dilatation.

Criteria

Inclusion Criteria:

- Vaginal delivery course.

- Patient with epidural anesthesia.

- Continous fetal heart-rate monitoring.

- Singleton pregnancy.

- Term pregnancy.

Exclusion Criteria:

- Suspected Chorioamnionitis.

- No epidural anesthesia.

- Multiple pregnancy.

- Fetal abnormality with emphasis on brain abnormalities.

- Preeclampsia.

- Patients refusing continous fetal heart-rate monitoring.

- Patients in need of a scalp electrode for fetal monitoring.

- Patients that received Dolestine during labor.

- Patients with Hepatitis B, Hepatitis C and HIV carriers or any other vertically
transmitted pathogenic agent.

Contacts and Locations

Contacts

Contact: Roy Lauterbach, MD 972-52-9432416 r_lauterbach@rambam.health.gov.il

Locations

Sponsors and Collaborators

Rambam Health Care Campus

Investigators

Principal Investigator: Roy Lauterbach, MD Rambam healthcare campus

More Information

  • Responsible Party: Rambam Health Care Campus
  • ClinicalTrials.gov Identifier: NCT03930277 History of Changes
  • Other Study ID Numbers: 0354-18-RMB
  • First Posted: April 29, 2019 Key Record Dates
  • Last Update Posted: May 4, 2021
  • Last Verified: May 2021
  • Individual Participant
    Data (IPD) Sharing
    Statement:

  • Plan to Share IPD: Undecided
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Additional relevant MeSH terms: Fetal Hypoxia Hypoxia